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Abstract: Trihydroxy[3.3.1]metacyclophane, which can be regarded as an unsymmetrical or 
incomplete "homocalix[3]arene", has been prepared from trimethoxy[3.3.1]metacyclophane by 
demethylation with trimethylsilyl iodide in MeCN. Di-O-methylation at the lower rim of 
trihydroxy[3.3.1]metacyclophane in the presence of K2CO3 in acetone afforded a novel 
inherently chiral calixarene–analogue, namely a macrocyclic [3.3.1]metacyclophane, 
possessing C1 symmetry. The inherent chirality of the two conformers was characterized by 1H 
NMR spectroscopy by addition of an excess of Pirkle's chiral shift reagent [(S)-(+)-1-(9-anthryl)-
2,2,2-trifluoroethanol], which caused a splitting of the OMe group and AB patterns 
corresponding to the methylene protons.  
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HIGHLIGHT 
 
♦ Calixarene analogue [3.3.1]metacyclophane was synthesized by TosMIC method followed by 
Wolf–Kishner reduction. 
♦ A chiral [3.3.1]metacyclophane was synthesized by selective O-methylation at lower rim of 
trihydroxy[3.3.1]metacyclophane. 
♦ All synthesized [3.3.1]metacyclophanes adopt partial-cone conformation except trihydroxy-
[3.3.1]metacyclophane. 
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1. Introduction 
Calixarenes and related macrocycles have been receiving considerable attention due to their 
host–guest chemistry as ionophoric receptors [1,2] and potential enzyme mimics in biology [3–
5]. The conformational characteristics of macrocyclic cyclophanes, especially those of 
calix[n]arenes, have been extensively investigated in the past decade [6,7]. Their phenolic 
hydroxyl groups are well ordered in a cyclic array due to strong intramolecular hydrogen 
bonding. C.D Gutsche reported [8] the role of hydrogen bonding in conformational mobolities of 
calix[n]arenes (n = 4–20). Kanters et al. have reported [9] that 27,28-diethoxy-p-tert-
butylcalix[4]arene exhibits interconversion due to intramolecular hydrogen bondings. Consid-
ering the role of the hydrogen bonding, it is surprising that reports on the preparation of 
calix[3]arenes and their analogues containing three benzene rings and the characterization of 
their conformational mobility due to hydrogen bonding has been very limited [10–14]. First suc-
cessful preparation of p-halocalix[3]arenes was reported in 1982 and no follow up reports have 
appeared [10]. This lack of research seems to be due to the much more strained structure of 
calix[3]arenes than larger calix[n]arenes. Homocalixarenes have been the subject of scientific 
interest for a couple of decades [14] and belong to a general class of calixarenes [1,2] in which 
the linker methylene bridges are partly or completely replaced by ethano or larger bridges [2,15, 
16]. Introduction of longer bridge into the methylene bridges of the conventional calixarenes, has 
rendered homocalixarene unique structural characteristics. One of the salient structural features 
is the self fine tuning of the conformations and the cavity sizes of the macrocycles. Such 
compounds have significantly different properties to those of their corresponding calixarene 
analogues. 
Shinkai and co-workers have reported [11,12] that the introduction of substituents at the 
hydroxyl groups of hexahomotrioxacalix[3]arene led to conformational rigid structures, i.e. fixed 
conformations such as cone and partial-cone. Among the numerous methods of chemical 
modification of calixarenes, the O-alkylation of the phenolic hydroxyl groups or modification at 
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upper rim is of great importance which leads to form inherent chirality in conventional 
calixarenes [12,17–21]. Inherently chiral calixarenes are unusual types of chiral calixarenes 
which are not based on a chiral subunit but due to the absence of a plane of symmetry or an 
inversion center in the molecule [22–25]. Inherently chiral calixarenes are considered as 
promising host molecules for molecular recognition [26,27] and asymmetric catalyst [17]. A 
large number of racemic inherently chiral calixarenes have been reported and some of them have 
been resolved into the enantiomerically pure form [22–25]. Replacement of the bridging 
methylene linkage by hetero-atoms have attracted considerable interest as a new members of 
calixarene family [28–31] and most recent technique to synthesize inherent chiral calixarene 
analogues [32]. However, there are few reports concerning the introduction of substituent's at the 
hydroxyl groups of asymmetric or incomplete homocalix[3]arenes having three conformers; i.e. 
cone and 2-partial-cone and 3-partial-cone conformers (Fig. 1).  
 
Insert Figure 1 in here 
 
Due to the intramolecular hydrogen bond interactions between the lower-rim phenolic 
hydroxy groups of conventional calix[4]arenes, it adopts stable cone, partial-cone, 1,3-alternate 
and 1,2-alternate conformations [6,7]. In contrast to the conventional calix[4]arenes, the 
conformational isomerism in the present system is slightly simple. Owing to the intrinsic 
structural features, we envisioned that calix[3]arenes would provide a unique platform for the 
construction of inherently chiral macrocycles and prompted us to attempt the synthesis of 
inherently chiral propane bridged homocalixarene [33]. The main objective of this research is to 
synthesize asymmetric or incomplete calixarene analogue inherently chiral 
[3.3.1]metacyclophane bearing two propane bridges. 
 
 
© 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ 
5 
 
2. Experimental 
General procedures 
All melting points (Yanagimoto MP-S1) are uncorrected. Proton nuclear magnetic 
resonance (1H NMR) and 13C NMR spectra were recorded on a Nippon Denshi JEOL FT-
300 NMR spectrometer and Varian-400MR-vnmrs400 spectrometer. Chemical shifts are 
reported as δ values (ppm) relative to internal Me4Si. Mass spectra were obtained on a 
Nippon Denshi JMS–01SA–2 mass spectrometer at an ionization energy of 70 eV; m/z 
values reported include the parent ion peak. Infrared (IR) spectra were obtained on a 
Nippon Denshi JIR-AQ2OM spectrophotometer as KBr disks. Elemental analyses were 
performed by Yanaco MT-5. G.L.C. analyses were performed by Shimadzu gas 
chromatograph, GC-14A; Silicone OV–1, 2 m; programmed temperature rise, 12 °C min-
1; carrier gas nitrogen, 25 mL min-1. Silica gel columns were prepared by use of Merk 
silica gel 60 (63–200 μm). 
Materials: TosMIC adduct 1 was prepared according to our reported data [34,35] and 1,1-bis(3-
bromomethyl-5-tert-butyl-2-methoxyphenyl)methane 2, was previously described [36]. 6,15,22-
Tri-tert-butyl-9,18,25-trimethoxy[3.3.1]metacyclophane-2,11-dione 3 was synthesized by the 
coupling reaction of  TosMIC adduct 1 with 2 according to reported procedure [37]. 
2.1 Synthesis of 6,15,22-tri-tert-butyl-9,18,25-trimethoxy[3.3.1]metacyclophane (4) 
A mixture of 3 (200 mg, 0.33 mmol), NaOH (200 mg, 5.0 mmol), 100 % hydrazine hydrate 
(0.35 mL, 6.2 mmol), and triethylene glycol (5 mL) was heated at 120 °C for 2 h and then at 
200 °C for 3 h. The cooled mixture was poured into water (50 mL), acidified with diluted HCl, 
and extracted with CH2Cl2 (5 u 30 mL), washed with water (2 u 20 mL), dried over Na2SO4, 
and concentrated under reduced pressure. The residue was purified on silica gel using benzene 
as eluents to give crude 4 as a white solid. Recrystallization from hexanes afforded 6,15,22-tri-
tert-butyl-9,18,25-trimethoxy[3.3.1]metacyclophane 4 (129 mg, 68 %) as white solid. M.p. 
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199–200°C. IR: Qmax (KBr)/cm-1: 2900, 2800, 1480, 1180 and 1000. 1H NMR (300 MHz, 
CDCl3): δ = 1.19 (9H, s, tBu), 1.27(18H, s, tBu × 2), 1.80 (3H, s, OMe), 1.98–2.28 (10H, m, 
CH2), 3.01 (2H, d, J = 2.19, CH2), 3.43 (1H, d, J = 12.1 Hz, CH2), 3.77 (6H, s, OMe), 4.50 (1H, 
d, J = 12.1 Hz, CH2), 6.81  (2H, s, Ar–H), 6.96 (2H, d, J = 2.5, Ar–H) and 7.35 (2H,d, J = 2.5 
Hz, Ar–H) ppm. 13C NMR (100 MHz, CDCl3): δ = 28.67 (CH2), 30.45 (CH2), 31.59 (C(CH3)3), 
31.77 (C(CH3)3), 32.66 (CH2), 34.02 (CH2), 34.08 (CH2), 58.41 (OCH3), 61.11 (OCH3), 124.08 
(ArC), 125.40 (ArC), 126.72 (ArC), 134.29 (ArC), 134.68 (ArC), 136.35 (ArC), 145.04 (ArC), 
145.21 (ArC), 154.32 (ArC) and 155.56 (ArC) ppm. FABMS: m/z: 584.45 [M+]. C40H56O3 
(584.89): calcd. C 82.14, H 9.65. Found: C 81.98, H 9.67.  
2.2 Synthesis of 6,15,22-tri-tert-butyl-18,25-dihydroxy-9-methoxy[3.3.1]metacyclophane (5) 
A solution of BBr3 (1 mL, 10.6 mmol) in CH2Cl2 (3 mL) was added gradually to a solution of 4 
(100 mg, 0.17 mmol) in CH2Cl2 (5 mL) at 0 °C. After the reaction mixture had been stirred at 
room temperature for 4 h, it was poured into ice-water (20 mL), extracted with CH2Cl2 (2 u 50 
mL), washed with water (2 u 10 mL), dried over Na2SO4, and concentrated in vacuo to give 
crude 5 as a white solid. Recrystallization from benzene afforded 6,15,22-tri-tert-butyl-18,25-
dihydroxy-9-methoxy[3.3.1]metacyclophane 5 (60 mg, 63 %) as white powder. M.p. 209–210 °C. 
IR: Qmax (KBr)/cm-1: 3625, 3320 (OH), 1495 and 1215. 1H NMR (300 MHz, CDCl3): δ = 1.22 
(9H, s, tBu), 1.28(18H, s, tBu × 2), 1.72 (3H, s, OMe), 1.76–2.35 (10H, m, CH2), 3.04 (2H, m, 
CH2), 3.61 (1H, d, J = 13.3 Hz, CH2), 4.36 (1H, d, J = 13.3 Hz, CH2), 6.29 (2H, s, OH, 
Exchanged by D2O), 6.90 (2H, s, Ar–H), 6.96 (2H, d, J = 2.5 Hz, Ar–H) and 7.25 (2H, s, Ar–H) 
ppm. 13C NMR (100 MHz, CDCl3): δ = 28.58 (CH2), 29.92 (CH2), 31.42 (CH2), 31.56 (C(CH3)3), 
31.58 (C(CH3)3), 31.76 (CH2), 33.93 (CH2), 34.15 (CH2), 58.25 (OCH3), 124.31 (ArC), 125.21 
(ArC), 126.81 (ArC), 127.58 (ArC), 128.16 (ArC), 136.36 (ArC), 143.15 (ArC), 145.78 (ArC), 
149.15 (ArC) and 154.17 (ArC) ppm. FABMS: m/z: 556.44 [M+]. C38H52O3 (556.8): calcd. C 
81.97, H 9.41. Found: C 81.67, H 9.17. 
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2.3 Synthesis of 6,15,22-tri-tert-butyl-9,18,25-trihydroxy[3.3.1]metacyclophane (6) 
To a mixture of CH3CN (16 mL) and CH2Cl2 (12 mL) compound 4 (180 mg, 0.31 mmol) and 
NaI (1.935 g, 12.9 mmol) was added. After adding trimethylsilyl chloride (2.0 mL), the mixture 
was stirred at 40–45 °C for 30 h. The reaction mixture was poured into 10 % aqueous 
thiosulphate solution (40 mL) and stirred for 1 h at room temperature. Then the mixture was 
stirred with 10 % HCl (20 mL) for 1 h and extracted with CH2Cl2 (3 u 40 mL). The combined 
mixture was washed with 10 % NaHCO3 (20 mL) and water (2 u 20 mL) and dried over Na2SO4 
and then concentrated under reduced pressure. The residue was purified on silica gel using 
methanol as eluent to give crude 6 as a white solid. Recrystallisation from CH2Cl2 afforded 
6,15,22-tri-tert-butyl-9,18,25-trihydroxy[3.3.1]metacyclophane 6 (140 mg, 83 %) as white solid. 
M.p. 230–231 °C. IR: Qmax (KBr)/cm-1: 3550, 3320 (OH), 1496 and 1210. 1H NMR (300 MHz, 
CDCl3): δ = 1.22 (9H, s, tBu), 1.27(18H, s, tBu × 2), 1.85 (4H, m, CH2), 2.30 (4H, m, CH2), 2.70 
(4H, s, CH2), 3.33 (1H, s, OH, Exchanged by D2O), 3.95 (2H, s, CH2), 6.25 (2H, s, OH, 
Exchanged by D2O), 6.86  (2H, s, Ar–H),  6.96 (2H, d, J = 4.5 Hz, Ar–H) and 7.24 (2H, d, J = 
2.4 Hz, Ar–H) ppm. 13C NMR (100 MHz, CDCl3): δ = 27.95 (CH2), 28.99 (CH2), 31.26 (CH2), 
31.51 (C(CH3)3), 31.61 (C(CH3)3), 31.79 (CH2), 33.88 (CH2), 33.96 (CH2), 124.21 (ArC), 125.63 
(ArC), 127.00 (ArC), 127.28 (ArC), 128.18 (ArC), 128.29 (ArC), 142.04 (ArC), 143.68 (ArC), 
148.50 (ArC) and 148.76 (ArC) ppm. FABMS: m/z: 542.44 [M+]. C37H50O3 (542.81): calcd. C 
81.87, H 9.28. Found: C 81.76, H 9.19.   
2.4 Synthesis of 6,15,22-tri-tert-butyl-25-hydroxy-9,18-dimethoxy[3.3.1]metacyclophane (8) and 
6,15,22-tri-tert-butyl-9,18-dihydroxy-25-methoxy[3.3.1]metacyclophane (7) 
A mixture of 6 (100 mg, 0.18 mmol) and potassium carbonate (500 mg, 3.62 mmol) in dry 
acetone (25 mL) was heated at reflux for 1 h under N2. Then MeI (0.25 mL, 3.7 mmol) was 
added and the mixture was heated at reflux for 0.5 h. After cooling of the reaction mixture to 
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room temperature, it was quenched with water, extracted with CH2Cl2 (2 u 20 mL). The 
combined organic extracts were washed with water (2 u 10 mL), dried over Na2SO4 and 
condensed under reduced pressure to afford a residue (yield 91 mg) containing a mixture of 
compounds 4, 7 and 8. The residue was purified on silica gel (Wako, C-300; 100 g) by using 
hexanes-benzene (1:1) as eluent to give the crude 8 (16 mg, 15 %) as a white solid. 
Recrystallization from methanol–CHCl3 (3:1) gave 6,15,22-tri-tert-butyl-25-hydroxy-9,18-
dimethoxy[3.3.1]metacyclophane 8 as white prisms. M.p. 203–204 °C. IR: Qmax (KBr)/cm-1: 
3566, 3395 (OH), 1492 and 1230. 1H NMR (300 MHz, CDCl3): δ = 1.15 (9H, s, tBu), 1.19 (9H, s, 
tBu), 1.20 (9H, s, tBu), 1.58 (3H, s, OMe), 1.71–2.21 (10H, m, CH2), 2.98–3.10 (2H, m, CH2), 
3.53 (1H, d, J = 13.2 Hz, CH2), 3.85 (3H, s, OMe), 4.16 (1H, d, J = 13.2 Hz, CH2), 6.78–6.81 
(2H, m, J = 3.0 Hz, Ar–H), 6.89 (1H, d, J = 2.4 Hz, Ar–H), 6.95 (1H, d, J = 2.4 Hz, Ar–H), 7.12 
(1H, d, J = 2.4 Hz, Ar–H), 7.26 (1H, d, J = 2.4 Hz, Ar–H) and 7.91 (1H, s, OH, Exchanged by 
D2O) ppm. 13C NMR (100 MHz, CDCl3): δ = 31.41 (CH2), 31.45 (C(CH3)3), 31.52 (C(CH3)3), 
34.09 (C(CH3)3), 34.22 (CH2), 34.31 (CH2), 37.40 (CH2), 41.69 (CH2), 41.99 (CH2), 42.25 (CH2), 
44.42 (CH2), 45.27 (CH2), 46.37 (CH2), 58.81 (OCH3), 60.76 (OCH3), 125.67 (ArC), 125.87 
(ArC), 126.10 (ArC), 126.27 (ArC), 126.39 (ArC), 126.55 (ArC), 126.80 (ArC), 126.92 (ArC), 
127.03 (ArC), 128.16 (ArC), 128.86 (ArC), 134.14 (ArC), 145.71 (ArC), 145.96 (ArC), 146.54 
(ArC), 153.79 (ArC), 154.02 (ArC) and 154.63 (ArC) ppm. FABMS: m/z: 570.43 [M+]. 
C39H54O3 (570.8): calcd. C 82.06, H 9.53. Found: C 82.18, H 9.47.  
Recrystallization from hexane-CH2Cl2 (1:1) afforded 6,15,22-tri-tert-butyl-9,18-dihydroxy-25-
methoxy[3.3.1]metacyclophane 7 (12.0 mg, 12 %) as white powder. M.p. 214–215 °C. IR: Qmax 
(KBr)/cm-1: 3564, 3308 (OH), 1498 and 1205. 1H NMR (300 MHz, CDCl3): δ = 1.21 (9H, s, 
tBu), 1.26 (9H, s, tBu), 1.27 (9H, s, tBu), 1.76–2.28 (10H, m, CH2), 2.85 (1H, s, OH, Exchanged 
by D2O), 3.08–3.16 (2H, m, CH2), 3.58 (1H, d, J = 13.5 Hz, CH2), 3.93 (3H, s, OMe), 4.17 (1H, 
d, J = 13.5 Hz, CH2), 6.81 (2H, s, Ar–H), 6.99 (2H, d, J = 6 Hz, Ar–H), 7.22 (1H, s, Ar–H), 7.28 
(1H, s, Ar–H) and 7.95 (1H, s, OH, Exchanged by D2O) ppm. 13C NMR (100 MHz, CDCl3): δ = 
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27.22 (CH2), 27.81 (CH2), 28.30 (CH2), 29.67 (CH2), 29.86 (CH2), 31.36 (C(CH3)3), 31.53 
(C(CH3)3), 31.62 (C(CH3)3), 32.00 (CH2), 32.37 (CH2), 33.80 (CH2), 33.89 (CH2), 34.17 (CH2), 
61.85 (OCH3), 123.87 (ArC), 124.11 (ArC), 125.17 (ArC), 125.54 (ArC), 127.18 (ArC), 127.67 
(ArC), 128.05 (ArC), 128.07 (ArC), 128.53 (ArC), 128.96 (ArC), 133.44 (ArC), 133.53 (ArC), 
141.57 (ArC), 142.75 (ArC), 147.52 (ArC), 148.82 (ArC), 149.73 (ArC) and 152.3 (ArC) ppm. 
FABMS: m/z: 556.38 [M+]. C38H52O3 (556.81): calcd. C 81.97, H 9.41. Found: C 81.86, H 9.31.   
2.5 Synthesis of 6,15,22-tri-tert-butyl-25-hydroxy-9,18-dimethoxy[3.3.1]metacyclophane (8) 
A mixture of 6 (100 mg, 0.18 mmol) and potassium carbonate (500 mg, 3.62 mmol) in dry 
acetone (25 mL) was heated at reflux for 1 h under N2. Then MeI (0.25 mL, 3.7 mmol) was 
added and the mixture was heated at reflux for 0.5 h. After cooling of the reaction mixture to 
room temperature, it was quenched with water, extracted with CH2Cl2 (2 u 20 mL). The 
combined organic extracts were washed with water (2 u 10 mL), dried over Na2SO4 and 
condensed under reduced pressure to afford a residue. The crude product was purified on silica 
gel (Wako, C-300; 100 g) by using hexanes-benzene (1:1) as eluent to give the product 8 (85 mg, 
83 %) as a white solid.  
3. Results and Discussion 
 6,15,22-Tri-tert-butyl-9,18,25-trimethoxy[3.3.1]metacyclophane-2,11-dione 3 was 
prepared by the coupling reaction of 2,6-bis(bromomethyl)-4-tert-butylanisole TosMIC adduct 
1 with 1,1-bis(5-tert-butyl-2-methoxyphenyl)methane 2 according to reported procedure [34–
37]. The modified Wolff–Kishner reduction of diketone 3 afforded 6,15,24-tri-tert-butyl-
9,18,27-trimethoxy[3.3.1]MCP 4 in 68 % yield (Scheme 1) as previously reported for the 
preparation of  [3.3]metacyclophane [34].  
 
Insert Scheme 1 in here 
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 The 1H NMR spectrum (CDCl3, 300 MHz) of macrocycle 4 presents two sets of doublets at 
δ 3.43, 4.50 ppm (J = 12.1 Hz) for the ArCH2Ar methylene protons and two single peaks at δ 
1.80 and 3.77 ppm for the methoxy protons. In this case, the two methoxy groups in the com-
pound point up and another one is point down, folded into the π-cavity formed by two benzene 
rings, shielded and appeared up field at δ 1.80 ppm. Thus, the compound 4 adopts an 
asymmetric 2-partial-cone conformation at room temperature as observed by two sets of 
doublets for the methylene protons. Demethylation of 4 with BBr3 in methylene dichloride 
afforded 6,15,22-tri-tert-butyl-18,25-dihydroxy-9-methoxy[3.3.1]metacyclophane 5 in 63 % 
yield. Attempts to further demethylate 5 with a large excess of BBr3 or by prolonging the 
reaction time were unsuccessful. No formation of the triol 6 was observed, and only the starting 
compound 5 was recovered in quantitative yield. Different reactivities towards BBr3 were thus 
observed in the present system.  
 
Insert Scheme 2 in here 
 This phenomenon could be attributed due to the 9–methoxy group of compounds 4 and 5 
inside the S–cavity of the two benzene rings of the diarylmethane being inert to attack by BBr3. 
These results are consistent with the difference of chemical shifts between these methoxy groups 
in 4. Yang et al developed a BBr3 and TMSI-mediated one-pot demethylation to synthesize an 
antifungal tricyclic o-hydroxy-p-quinone methide diterpenoid and analogues [38]. Interestingly, 
an extended demethylation reaction of 4 and 5 with trimethylsilyl iodide in MeCN afforded the 
desired triol 6 in 83 % and 90 % yield, respectively.  
The IR (KBr) spectrum of 5 shows the absorption for the hydroxyl stretching vibration at 
around 3320 cm-1. The 1H NMR spectrum (CDCl3, 300 MHz) exhibits signals for the hydroxyl 
groups at around δ 6.29 ppm (exchanged by D2O). This data is consistent with the existence of 
intramolecular hydrogen bonding between the two hydroxyl groups of the diarylmethane linkage 
of cyclic product 5, but not the diarylpropane linkage. The intramolecular hydrogen bonded O–H 
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band is a broad peak appear at 3320 cm-1 and the free O–H band is a sharp peak appear at 3625 
cm-1. The 1H NMR spectrum of macrocycle 5 presents two sets of doublets at δ 3.61 and 4.36 
ppm (J = 13.3 Hz) for the ArCH2Ar methylene protons and one single peak at δ 1.72 ppm for the 
methoxy protons. These patterns correspond to the former conformer given that the two 
methylene protons ArCH2Ar and methoxy protons are all in different environments, whereas the 
latter conformer should exhibit a set of doublets for the methylene protons ArCH2Ar and a 
singlet for the methoxy protons due to the C2-symmetry (Fig. 1). 
 
Insert Figure 2 in here 
 
  The crystal structure of 5 (CCDC 908364) was found to belong to the monoclinic crystal 
system with space group P21/n (SI Table S1). The X-ray structure also supports the 1H NMR 
spectrum (Fig. 2). It is clear that one methoxy group is present between two aromatic rings which 
is experiencing ring current by the π-aromatic electrons as predicted from the 1H NMR data. The 
distance between H (OH) and Ol (OH) is 1.82 Å, which is a reasonable distance for 
intramolecular hydrogen bonding. In contrast, both the 1H NMR spectrum and single crystal 
analysis confirmed the 2-partial-cone conformation of macrocycle 5. 
 The IR (KBr) spectrum of 6 shows the absorption of the hydroxyl stretching vibration a 
broad band at around 3320 cm-1 for intramolecular hydrogen bonding and a sharp peak at 3550 
cm-1 for free hydroxyl stretching. The 1H NMR spectrum (in CDCl3) exhibits the signals for the 
hydroxyl groups at around δ 3.33 and 6.25 ppm (exchanged by D2O) which is the evidence for 
the formation of intramolecular hydrogen bonding between two hydroxyl groups of the 
diarylmethane linkage of cyclic product 6. However, it is weaker than the corresponding 
calix[4]arenes due to the flexibility of the propane linkages in spite of having a smaller ring size. 
The 1H NMR spectrum of 6 indicates that it adopts a cone conformation at room temperature 
[23] and the methylene proton appears as a singlet at δ 3.95 ppm. Gutsche and co-workers 
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reported [6] that the strong intramolecular hydrogen bonding of calix[4]arenes may fix the cone 
conformation.  
   We have succeeded in synthesizing both trihydroxy[3.3.1]metacyclophane 6 and 
dihydroxy[3.3.1]metacyclophane 5; one regio–isomer expected to have a chirality 
monohydroxy[3.3.1]metacyclophane 8 is still remains to be synthesized. Thus, there is 
substantial interest to synthesize this compound via O-methylation of the phenolic oxygen 
using MeI in the presence of base.  
 
Insert Scheme 3 in here 
Insert Table 1 in here 
 
 O-Methylation of trihydroxy[3.3.1]metacyclophane 6 using MeI in presence of NaH as a 
base, exclusively afforded the corresponding tri-O-methylated product 4 in 90 % yield. 
On the other hand, when Na2CO3 is employed, only the trihydroxy compound 6 was 
recovered in 92 %, even when a large excess of Na2CO3 was used. Interestingly, when 
K2CO3 is used in this reaction for 0.5 h, the mono-O-methylated product 7 and di-O-
methylated product 8 were obtained in 21 and 26 % yields, along with the recovery of the 
starting compound 6 in 53 % yield. On increasing the reaction time to 3 h, the yield of the 
di-O-methylation product 8 increased to 93 %. Thus, in the case of K2CO3, selective di-O-
methylation was observed. On increasing further the reaction time to 12 h, the yield of the 
tri-O-methylation product 4 was increased to 85 %. In contrast, when Cs2CO3 is em-
ployed, the reaction was completed within 3 h with the exclusive formation of the tri-O-
methylated product 4 and the O-methylation results are summarized in Table 1. 
 
Insert Table 2 in here 
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The 1H NMR (CDCl3, 300 MHz) spectrum of macrocycle 7 showed three single peaks for the 
tert-butyl protons at δ = 1.21, 1.26 and 1.27 ppm (relative intensity 1:1:l). These signals 
correspond to an unsymmetrical structure. Two hydroxyl groups give singlet peaks at δ 2.85 and 
7.95 ppm and both are exchanged by D2O. The peak at high field (δ 7.95 ppm) indicates the 
formation of intramolecular hydrogen bonding between MeO…HO. The IR (KBr) spectrum of 7 
shows the absorption peaks of the hydroxyl stretching vibration at around 3564 and 3308 cm-1 
evidence for the existence of intramolecular hydrogen bonding. The splitting pattern of the 
ArCH2Ar methylene protons at δ 3.58 and 4.17 ppm (J = 13.5 Hz) indicates that compound 7 
adopts a 2-partial-cone conformation.   
The 1H NMR spectrum (CDCl3, 300 MHz) of macrocycle 8 exhibits two sets of doublets due 
to the bridging methylene protons and three single peaks for the tert-butyl protons at δ = 1.15, 
1.19 and 1.20 ppm (relative intensity 1:1:l). This indicates that macrocycle 8 adopts an asym-
metric 2-partial-cone conformation at room temperature. In this conformation, the one methoxy 
group in the compound 8 is point up and another is point down with folded into the π–cavity by 
two benzene rings which causes upfield shift of this methoxy group at δ 1.58 ppm. The IR (KBr) 
spectrum of 8 shows the absorption for the hydroxyl stretching vibration at around 3566 and 
3395 cm-1 due to free and intramolecular hydrogen bonding of hydroxyl group. The 1H NMR 
spectral data of [3.3.1]MCPs 4, 5, 6, 7 and 8 are summarized in Table 2. 
 
Insert Figure 3 in here 
 
Macrocycle 8 is expected to have a plane of chirality, because it has two types of substituents 
and bridged linkages which are fixed and the C1 symmetrical conformer does not show 
conformational change at room temperature. Shinkai and co-workers introduced two kinds of 
substituents at the lower rim of homo-oxacalix[3]arenes to synthesis  C2 symmetry inherent 
chirality [12]. Böhmer and co-workers [39,40] demonstrated the chirality of dissymmetric 
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calix[4]arenes with C2 and C4symmetry by interaction with Pirkle's reagent [(S)-(+)-1-(9-
anthryl)-2,2,2-trifluoroethanol]. The 1H NMR (CDCl3, 400 MHz) spectrum of compound 8 in the 
absence and the presence of Pirkle's reagent is shown in Fig. 3. It is reported [39] that hydroxyl 
groups which do not participate in intramolecular hydrogen bonding are necessary for an 
effective interaction between chiral calix[4]arenes and Pirkle's reagent. In the spectrum of 
compound 8, one of the singlet peaks of the methoxy groups and all peaks of the bridged protons 
are splitted on addition of Pirkle's reagent due to the formation of two diastereomeric complexes 
(Fig. 3). These findings suggest that one methoxy and a hydroxyl group of 8 play an important 
role to coordinate with Pirkle's reagent. 
 
Insert Figure 4 in here 
     Chromatographic resolution using a chiral column was attempted for the present di-O-
methylation derivative 8. Interestingly, compound 8 exhibits two well resolved peaks in the ratio 
of 50:50 for P and M-enantiomers as presented in Fig. 4(a). This finding strongly suggests that 
the resolution of racemic 8 could be achieved by chromatographic separation using a chiral 
column. In fact, we have succeeded in resolving each P and M-enantiomers. The circular 
dichroism (CD) spectra of the separated enantiomers with perfect mirror images are shown in Fig. 
4(b). In fact, we have succeeded to generate inherent chirality in metacyclophane system 
containing three benzene rings by regio-selective O-methylation at lower rim of calixarene 
analogue [3.3.1]metacyclophane 6. 
Conclusions 
We have for the first time provided an effective and practical method for the synthesis of 
calixarene analogue trihydroxy[3.3.1]metacyclophanes 6, which is regarded as an unsymmetrical 
or incomplete "homocalixarene", bearing one methylene and two propane bridges. Di-O-
methylation of the hydroxyl groups of triol 6 with MeI in presence of K2CO3 afforded to yield a 
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2-partial-cone conformer 8, which has a plane of chirality, given that the two types of substituent 
and bridges are fixed in a C1-symmetrical structure. All synthesized [3.3.1]metacyclophanes 
exhibit rigid 2-partial-cone conformations in solution except trihydroxy[3.3.1]metacyclophane 6 
which has a flexible cone conformation at room temperature. Further mechanistic details of O-
alkylation and uses as enantioselective artificial receptors, are ongoing and will be reported in 
future. 
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Dear Editor: 
We would like to submit the manuscript entitled “Synthesis and conformational studies of 
calixarene analogue chiral [3.3.1]metacyclophanes” for consideration as an article in Journal of 
Molecular Structure. 
A homocalixarene is analogue to calixarene, where methylene groups of the bridge linkage 
were changed to other functional groups partially or totally. All of these calixarenes analogous 
have the similar characteristics to that of calixarene. Furthermore, with different bridge linkage, 
they have special properties. Homocalixarenes have been utilized in different fields of 
chemistry like conformational analysis, molecular recognition, organic catalysts etc. There are 
few reports concerning on the unsymmetric or uncomplete calix[n]arenes. Again it is surprising 
that reports on the preparation of calix[3]arenes and their analogue containing three benzene 
rings have been very limited. This facts seem to be due to the much more strained structure of 
calix[3]arenes than calix[n]arenes containing the larger ring 
Herein, we have synthesized for the first time trihydroxy[3.3.1]metacyclophane, which is 
regarded as an unsymmetrical or incomplete "homocalix[3]arene" from trimethoxy[3.3.1]- 
metacyclophane by demethylation with trimethylsilyl iodide in MeCN. Weak intramolecular 
hydrogen bonding was observed in the trihydroxy[3.3.1]metacyclophane. An interesting result 
was obtained by O-methylation of the trihydroxy[3.3.1]metacyclophane with methyl iodide in  
presence of K2CO3, which formed the inherently chiral di-O-methylation product. Inherently 
chiral calixarenes are considered as promising host molecules for enantio-recognition and 
enantio-separation of chemically and/or biologically important chiral guest molecules. 
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Fig. 1. Possible conformers for [3.3.1]metacyclophanes. 
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Fig. 2. Ortep drawing of [3.3.1]metacyclophane 5. Thermal ellipsoids are drawn at the 50 % 
probability level. All hydrogen atoms except two are omitted for clarity 
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Fig. 3. Partial 1H NMR spectra (CDCl3; 400 MHz); (a) 8, (b) 8+ Pirkle’s reagent. 
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Fig. 4. (a) Chromatogram of 8 (HPLC on chiral column). Daicel chiralpak AD–H. Eluent: 
hexanes. (b) CD spectra of P- and M-enantiomers of inherently chiral MCP 8. 
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Table 1 O-Methylation of 9,18,25-trihydroxy[3.3.1]metacyclophane 6 with MeI in the presence 
of M2CO3 or NaH. 
 
Run 
 
Base  
 
Time 
(hr)  
 ProductsYield(%)a,b 
Recovered                            
 7 8 4 6 
1 NaHc 3 0  0  100 (90)  0                       
2 Na2CO3 12 0 0 0 100 (92) 
3 K2CO3 0.5 21 (12) 26 (15) 0 53 
4 K2CO3 3 0  93 (83) 7  0 
5 K2CO3 12 0 15 85 (65)  0                         
6 Cs2CO3 3 0 0 100 (81)  0  
aYields were determined by 1H-NMR analyses. bIsolated yields are shown in parentheses. 
cSolvent: THF-DMF (4:1 v/v).   
 
 
 
Table 2 1H-NMR data for the [3.3.1]metacyclophanes 4–8 in CDCl3.a 
Compound Methylene bridge 
protons 
 
OH-Protons 
 
O-Me 
protons 
 
Assignment 
e a J (Hz) 
4 3.43 4.50 12.1 – 1.80, 3.77 partial-cone 
5 3.61 4.36 13.3 6.29 1.72 partial-cone 
6 3.95 – singlet 3.33, 6.25 – cone 
7 3.58 4.17 13.5 2.85, 7.95 3.93 partial-cone 
8 3.60 4.23 13.1 7.91 1.58, 3.85 partial-cone 
aChemical shifts are expressed in ppm (δ) against TMS as internal standard; coupling 
constants are given in Hz, a stands for axial, e for equatorial. 
 
 
 
 
 
Table(s)
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Figure S1-1 1H-NMR spectrum (300 MHz, 298 K, * CDCl3) for 3. 
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Figure S1-2 1H-NMR spectrum (300 MHz, 298 K, * CDCl3) for 4. 
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 Figure S1-3 1H-NMR spectrum (300 MHz, 298 K, * CDCl3) for 5. 
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Figure S1-4 1H-NMR spectrum (300 MHz, 298 K, * CDCl3) for 5 with D2O. 
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Figure S1-5 1H-NMR spectrum (300 MHz, 298 K, * CDCl3) for 6. 
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Figure S1-6 1H-NMR spectrum (300 MHz, 298 K, * CDCl3) for 6 with D2O. 
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 Figure S1-7 1H-NMR spectrum (100 MHz, 298 K, * CDCl3) for 7. 
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Figure S1-8 1H-NMR spectrum (300 MHz, 298 K, * CDCl3) for 7 with D2O. 
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Figure S1-9 1H-NMR spectrum (300 MHz, 298 K, * CDCl3) for 8.  
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Figure S1-10 1H-NMR spectrum (300 MHz, 298 K, * CDCl3) for 8 with D2O. 
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Figure S1-11 13C-NMR spectrum (100 MHz, 298 K,  CDCl3) for 3. 
 
 
Figure S1-12 13C-NMR spectrum (100 MHz, 298 K,  CDCl3) for 4.  
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 Figure S1-13 13C-NMR spectrum (100 MHz, 298 K,  CDCl3) for 5. 
 
 
 
Figure S1-14 13C-NMR spectrum (100 MHz, 298 K,  CDCl3) for 6. 
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 Figure S1-15 13C-NMR spectrum (100 MHz, 298 K,  CDCl3) for 7. 
        
 
 
 
Figure S1-16 13C-NMR spectrum (100 MHz, 298 K,  CDCl3) for 8. 
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Figure S2-1 FT-IR spectrum for 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2-2 FT-IR spectrum for 4. 
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Figure S2-3 FT-IR spectrum for 5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2-4 FT-IR spectrum of the compound 6. 
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Figure S2-5 FT-IR spectrum for 7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2-6 FT-IR spectrum for 8. 
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 Figure S3-1 Mass spectrum for 3. 
 
Figure S3-2 Mass spectrum for 4. 
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 Figure S3-3 Mass spectrum for 5. 
 
Figure S3-4 Mass spectrum for 6. 
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 Figure S3-5 Mass spectrum for 7. 
 
Figure S3-6 Mass spectrum for 8. 
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                      Figure S4-1 1H-NMR spectrum (CDCl3; 400 MHz) for 8 with Pirkle’s reagent. 
 
 
© 2015, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/ 
X-ray crystallography 
 
Table S1 Summary of crystal data for 5.a,b 
Parameter 5 
Empirical formula C38 H52 O3 
Formula weight [g mol-1] 556.80 
Crystal system monoclinic 
Space group P21/n 
A  [Å] 13.1224(5) 
B  [Å] 14.4709(10) 
C  [Å] 17.6162(12) 
α  [°] 90.0000 
β  [°] 91.595(4) 
γ  [°] 90.0000 
Volume [Å3] 3343.9(3) 
Z 4 
Density, calcd [g m-3] 1.106 
Temperature [K] 100(2) 
Unique reflns 6270 
Obsd reflns 4089 
Parameters 381 
Rint 0.0973 
R[I>2σ(I)]a 0.0586 
wR[I>2σ(I)]b 0.1503 
GOF on F2 1.030 
 
a
 Conventional R on Fhkl: Σ||Fo| – |Fc||/σ|Fo|. b Weighted R on |Fhkl|2: Σ[w(Fo2 – Fc2)2]/Σ[w(Fo2)2]1/2 
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checkCIF/PLATON report 
Structure factors have been supplied for datablock(s) I
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW PROCEDURE
FOR PUBLICATION, IT SHOULD NOT REPLACE THE EXPERTISE OF AN EXPERIENCED
CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.        CIF dictionary        Interpreting this report
Datablock: I 
Bond precision: C-C = 0.0032 A Wavelength=0.71073
Cell: a=13.1224(5) b=14.4709(10) c=17.6162(12)
alpha=90 beta=91.595(4) gamma=90
Temperature: 100 K
Calculated Reported
Volume 3343.9(3) 3343.9(3)
Space group P 21/n P 21/n 
Hall group -P 2yn ? 
Moiety formula C38 H52 O3 ?
Sum formula C38 H52 O3 C38 H52 O3
Mr 556.80 556.80
Dx,g cm-3 1.106 1.106
Z 4 4
Mu (mm-1) 0.068 0.068
F000 1216.0 1216.0
F000’ 1216.49
h,k,lmax 15,17,21 15,17,21
Nref 6349 6270 
Tmin,Tmax 0.985,0.995
Tmin’ 0.985
Correction method= Not given
Data completeness= 0.988 Theta(max)= 25.680
R(reflections)= 0.0586( 4089) wR2(reflections)= 0.1503( 6270)
S = 1.030 Npar= 381
The following ALERTS were generated. Each ALERT has the format
       test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.
Supplementary Material
Click here to download Supplementary Material: Check cif for compound 5.pdf
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 Alert level B
PLAT420_ALERT_2_B D-H Without Acceptor       O1     -   H1     ...     Please Check 
 Alert level C
PLAT048_ALERT_1_C MoietyFormula Not Given ........................     Please Do ! 
PLAT125_ALERT_4_C No ’_symmetry_space_group_name_Hall’ Given .....     Please Do ! 
PLAT242_ALERT_2_C Low       Ueq as Compared to Neighbors for .....         C7 Check 
 Alert level G
PLAT005_ALERT_5_G No _iucr_refine_instructions_details  in the CIF     Please Do ! 
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms ..............          2 Report
PLAT899_ALERT_4_G SHELXL97   is Deprecated and Succeeded by SHELXL       2014 Note  
   0 ALERT level A = Most likely a serious problem - resolve or explain
   1 ALERT level B = A potentially serious problem, consider carefully
   3 ALERT level C = Check. Ensure it is not caused by an omission or oversight
   3 ALERT level G = General information/check it is not something unexpected
   1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data
   2 ALERT type 2 Indicator that the structure model may be wrong or deficient
   0 ALERT type 3 Indicator that the structure quality may be low
   2 ALERT type 4 Improvement, methodology, query or suggestion
   2 ALERT type 5 Informative message, check
checkCIF publication errors
 Alert level A
PUBL004_ALERT_1_A  The contact author’s name and address are missing,
            _publ_contact_author_name and _publ_contact_author_address.
PUBL005_ALERT_1_A  _publ_contact_author_email, _publ_contact_author_fax and
            _publ_contact_author_phone are all missing.
            At least one of these should be present.
PUBL006_ALERT_1_A  _publ_requested_journal is missing
            e.g. ’Acta Crystallographica Section C’
PUBL008_ALERT_1_A  _publ_section_title is missing. Title of paper.
PUBL009_ALERT_1_A  _publ_author_name is missing. List of author(s) name(s).
PUBL010_ALERT_1_A  _publ_author_address is missing. Author(s) address(es).
PUBL012_ALERT_1_A  _publ_section_abstract is missing.
            Abstract of paper in English.
 Alert level G
PUBL017_ALERT_1_G The _publ_section_references section is missing or
            empty.
   7 ALERT level A = Data missing that is essential or data in wrong format
   1 ALERT level G = General alerts. Data that may be required is missing
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Publication of your CIF 
You should attempt to resolve as many as possible of the alerts in all categories. Often the minor
alerts point to easily fixed oversights, errors and omissions in your CIF or refinement strategy, so
attention to these fine details can be worthwhile. In order to resolve some of the more serious
problems it may be necessary to carry out additional measurements or structure refinements.
However, the nature of your study may justify the reported deviations from journal submission
requirements and the more serious of these should be commented upon in the discussion or
experimental section of a paper or in the "special_details" fields of the CIF. checkCIF was
carefully designed to identify outliers and unusual parameters, but every test has its limitations and
alerts that are not important in a particular case may appear. Conversely, the absence of alerts does
not guarantee there are no aspects of the results needing attention. It is up to the individual to
critically assess their own results and, if necessary, seek expert advice.
If level A alerts remain, which you believe to be justified deviations, and you intend to submit this
CIF for publication in a journal, you should additionally insert an explanation in your CIF using
the Validation Reply Form (VRF) below. This will allow your explanation to be considered as part
of the review process.
Validation response form
Please find below a validation response form (VRF) that can be filled in and pasted into your CIF.
# start Validation Reply Form
_vrf_PUBL004_GLOBAL
;
PROBLEM: The contact author’s name and address are missing,
RESPONSE: ...
;
_vrf_PUBL005_GLOBAL
;
PROBLEM: _publ_contact_author_email, _publ_contact_author_fax and
RESPONSE: ...
;
_vrf_PUBL006_GLOBAL
;
PROBLEM: _publ_requested_journal is missing
RESPONSE: ...
;
_vrf_PUBL008_GLOBAL
;
PROBLEM: _publ_section_title is missing. Title of paper.
RESPONSE: ...
;
_vrf_PUBL009_GLOBAL
;
PROBLEM: _publ_author_name is missing. List of author(s) name(s).
RESPONSE: ...
;
_vrf_PUBL010_GLOBAL
;
PROBLEM: _publ_author_address is missing. Author(s) address(es).
RESPONSE: ...
;
_vrf_PUBL012_GLOBAL
;
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PROBLEM: _publ_section_abstract is missing.
RESPONSE: ...
;
# end Validation Reply Form
If you wish to submit your CIF for publication in Acta Crystallographica Section C or E, you
should upload your CIF via the web. If your CIF is to form part of a submission to another IUCr
journal, you will be asked, either during electronic submission or by the Co-editor handling your
paper, to upload your CIF via our web site.
PLATON version of 20/08/2014; check.def file version of 18/08/2014 
Datablock I - ellipsoid plot
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